BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal ...
BioStem remains committed to advancing evidence-based innovation in wound care through rigorous clinical research and real-world data analysis, supported by its proprietary BioRetain ® process and ...
If the FDA follows through with the proposed guidelines, and they are not fatally twisted by pressure from the medical ...
The US Food and Drug Administration (FDA) is now “open to bayesian statistics,” contrasting this with the frequentist approach that the agency and the drug industry have historically relied on for ...
Current guidelines lack clear, consistent recommendations on liver-beneficial exercise for metabolic dysfunction-associated ...
Treatments for a rare, aggressive form of childhood brain cancer that researchers describe as promising may move closer to clinical adoption because of a new analysis method that strengthens evidence ...
WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...
Bayesian thinking helps you make better decisions by updating your beliefs when new evidence appears. Even in games of chance like scratch-off lotteries, paying attention to information can improve ...
This webinar introduced healthcare researchers to Bayesian meta-analysis methods, challenging the perception that these methods are inaccessible to non-statistical researchers. The session ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results